刘昕
个人简历

基本信息
刘昕,男,汉族,1987.08出生,理学博士,江苏省双创博士,副教授,硕士生导师
教育经历
2017年9月博士毕业于南京大学化学化工学院化学专业
工作经历
2017-10至2018-08,美康生物科技股份有限公司
2018-09至2022-09,南通大学,药学院,讲师
2022-10至 今,南通大学,药学院,副教授
研究方向
超分子纳米药物及共价有机框架材料的可控自组装
基金项目
国家自然科学基金青年项目,项目号:22001133,30万,主持
南通市科技计划项目,项目号:JC2020075,3万,主持
国家自然科学基金面上项目,项目号:82473840,48万,参与
科研成果
以第一作者/通讯作者在Biosensors and Bioelectronics、Journal of Colloid and Interface Science、ACS Applied Materials & Interfaces、International Journal of Biological Macromolecules、Chemistry of Materials、Chinese Chemical Letters、Chemical Communications等国际期刊上发表论文多篇。
近五年代表性论文
1.Xin Liu*, Weizhi Tao, Chen Gong, Sijia Wang, Yiliang Wu, Yanan Zhang, Yong Ling*. Supramolecular nanoagent as a dual-blocked thermoresistance inhibitor for effective mild-temperature photothermal therapy,Biosens. Bioelectron., 2025, 278, 117322.
2.Xin Liu*, Yiliang Wu, Jiaxin Zheng, Yanan Zhang, Yong Ling. Glucose oxidase-loaded supramolecular nanocatalyst for nitric oxide and chemodynamic synergistic therapy via in situ cascade reactions,Int. J. Biol. Macromol., 2025, 333, 148894.
3.Xin Liu*, Ji Liu, Qin Xu, Weizhi Tao, Xudong Xie, Chi Meng, Qinbei Zhou, Yanan Zhang, Yong Ling*. A versatile supramolecular nanoagent for three-pronged boosting chemodynamic therapy,J. Colloid Interface Sci., 2023, 648, 994-1005.
4. Chi Meng, Xudong Xie, Jianqiang Qian, Weizhi Tao, Hongmei Wu, Dongliang Ji, Ge Gao, Ruojia Wang, Changchun Ling, Yanan Zhang,Xin Liu*, Yong Ling*. TME-targeting nano-theranostic agent for NIR fluorescence diagnosis and O2-economized PDT-based multimodal synergistic therapy.Mater. Des., 2023, 233, 112251.
5.Xin Liu*, Ji Liu, Chi Meng, Peng Zhu, Xiao Liu, Jianqiang Qian, Shijia Ling, Yanan Zhang, Yong Ling*. Pillar[6]arene-based supramolecular nanocatalysts for synergistically enhanced chemodynamic therapy by the intracellular cascade reaction.ACS Appl. Mater. Interfaces, 2021, 13, 53574-53585.
6.Xin Liu*, Chi Meng, Guiqing Ji, Ji Liu, Peng Zhu, Jianqiang Qian, Shun-Xing Zhu, Yanan Zhang, Yong Ling*. Tumor microenvironment-activatable Boolean logic supramolecular nanotheranostics based on a pillar[6]arene for tumor hypoxia imaging and multimodal synergistic therapy,Mater. Chem. Front., 2021, 5, 5846.
7. Peng Zhu, Weidan Luo, Jianqiang Qian, Chi Meng, Wenpei Shan, Zhongyuan Xu, Wei Zhang,Xin Liu*, Yong Ling*. GSH/ROS dual-responsive supramolecular nanoparticles based on pillar[6]arene and betulinic acid prodrug for chemo–chemodynamic combination therapy,Molecules, 2021, 26, 6900.
8.Xin Liu, Kaiya Wang, Marlen Externbrink, Jochen Niemeyer, Michael Giese, Xiao-Yu Hu*. Control of secondary structure and morphology of peptide– guanidiniocarbonylpyrrole conjugates by variation of the chain length,Chin. Chem. Lett., 2020, 31, 1239-1242.